semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-40.0,  Obesity Lifestyle-related Condition Macrosomia, Fetal All subjects will have had by the time of randomization at 3 months postpartum: 1. Planning another pregnancy within the next 24 months 2. Planning to deliver at Tufts medical center during their next pregnancy 3. A previous full-term singleton pregnancy (gestational age > 37 weeks) 4. 18 to 40 years of age at the time of enrollment into the study 5. Vaginal or cesarean delivery 6. Normal glucose tolerance or gestational diabetes (GDM), but without evidence of postpartum diabetes as defined by a 75 g 2-hr oral glucose tolerance test (OGTT) 7. Normal blood pressure or mild preeclampsia but normal postpartum blood pressure 8. Bottle or breast feeding 9. Normal thyroid function (determined by TSH concentration in blood), normal cell blood count and normal kidney and liver functions. Lipid profile with triglyceride levels not higher than 400 mg/dl (fasting) and LDL levels less than 180 mg/dL 10. No clinical signs or symptoms of cardiovascular disease or any other disease or condition that may contraindicate participation in exercise training (i.e. COPD, severe asthma, orthopedic abnormalities) 11. Using contraception  Pre or post-delivery diabetes 2. Post-delivery hypertension requiring medication 3. asthma requiring more than occasional use of a sympathomimetic inhaler, but not chronic inhaled steroids 4. Inflammatory bowel disease 5. Need for assisted reproductive technologies to become pregnant 6. Medical or obstetrical contraindication to the defined exercise program or diet 7. Tobacco, excessive alcohol use (greater than 2 drinks/day) or illicit drug use 8. Eating disorders such as bulimia 9. Gastric surgery to lose weight including banding or bypass procedures 10. Any psychological or psychiatric condition which may impair participation in the lifestyle intervention program 11. Multiple pregnancy 12. HIV, or hepatitis B or C 13. If a LIPP subject becomes pregnant prior to 16 weeks after randomization before the weight loss phase for the lifestyle intervention is completed or a control subject becomes pregnant before the 3 month postpartum randomization, i.e. no baseline measurement
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Sepsis Sepsis Severe Sepsis Septic Shock  On glucocorticoids On Vitamin A On any active medical research study Failed ACTH stimulation test (All serum cortisol concentrations < 20 mg/dl)
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 14.0-45.0,  Eating Disorder Age between 14 and 45 years Diagnosis of Eating Disorder that meets DSM 5 diagnostic for Anorexia Nervosa (AN), Bulimia Nervosa (BN) or Other Specified Feeding or Eating Disorder (OSFED) A clinical severity which permits to treat the person at out-patient level  Eating Disorder of high clinical severity, not treatable at out-patient level Comorbidity with psychotic symptoms or any other DSM 5 disorder which might hinder eating disorder treatment Medical conditions which might impede data interpretation (chemotherapy, pregnancy status) Substances use and abuse Having previously received an evidence-based CBT treatment for the same eating disorder and/or EMDR
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 15.0-65.0,  Eating Disorder Patient with an eating disorder according to Diagnostic and Statistical Manuel of Mental disorders-V (DSM-V) Patient aged from 15 to 65 years Patient who performs the day-hospital evaluation Patient affiliated to a French social security system Patient able to understand the nature, the aim and the methodology of the study For minor one of the legal guardians gave his consent  Patient in an unstable somatic state (eg severe metabolic disorder making impossible or unreliable neuropsychological assessments) Patient's refusal to participate Patient on protective measures (guardianship or trusteeship) Pregnant or nursing women. A dosage of beta human chorionic gonadotropin (βHCG) will be performed to ensure the absence of pregnancy
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Diabetes Mellitus, Type 2 Overweight Age 18-65 years BMI 23.5 kg/m2 Diabetes more than two years and less than ten years American Society of Anesthesiologists (ASA) classification < 4 Able to give informed consent  Age: below 18 and above 65 Inability to informed consent Patients on GLP-1 agonist and insulin two weeks before admission into the trial Diabetes more than ten years or less than two years C-Peptide level < 2.0 ng/mL American Society of Anesthesiologists (ASA) classification > 3 Logistic issue where patient come from rural area and has difficulty in complying with the post-operation close monitoring and follow-up Patient who has psychiatric disorder (depression, substance abuse, eating disorder, alcoholism, dementia etc.)
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cachexia Patients identified at multidisciplinary team meetings (MDT) as having oesophagogastric, hepatobiliary, and colorectal cancer suitable for resection Patients over 18 years of age Patients identified at surgical clinic as being planned for an abdominal operation for a non-cancer, non-inflammatory condition  Patients with inflammatory conditions or other condition other than cancer that might cause muscle wasting Patients without the capacity to consent Members of vulnerable groups Patients not undergoing abdominal surgery Patients undergoing totally minimally invasive (laparoscopic) surgery, with no open or hand-assisted component affording easy access to rectus muscle biopsy
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Hypercholesterolemia Age ≥18 years or legal age of majority depending on regional law Fasting, calculated LDL-C at screening ≥160 mg/dL and following PCSK9i therapy ≥70 mg/dL Men and nonpregnant, nonlactating women  Heterozygous (HeFH) or Homozygous (HoFH) Familial Hypercholesterolemia Total fasting TG ≥500 mg/dL Renal dysfunction or a glomerulonephropathy; eGFR <30 mL/min/1.73 m2 Known cardiovascular disease (CVD), peripheral arterial disease (PAD), or cerebrovascular disease (CD) History of type 1 or type 2 diabetes Uncontrolled hypertension Uncontrolled hypothyroidism Liver disease or dysfunction Gastrointestinal conditions or procedures (including Lap-Band® or gastric bypass) History of hematologic or coagulation disorders
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 60.0-80.0,  Vitamin D Deficiency Diabetes Mellitus Hypertension Lipid Metabolism Disorders Obesity, Abdominal Food insecure Have fit of metabolic syndrome; (WC>90 cm), obesity (BMI≥30 kg/m2), diabetes (FBS>100 mg/dl), high blood pressure (systolic >135 mmHg and diastolic >85 mmHg) and dyslipidaemia (LDL≥ 240 mg/dl, HDL<40 mg/dl, TC≥ 160 mg/dl; TG≥ 200 mg/dl) Vitamin D deficient; serum 25(OH) D level <30 ng/ml No use of vitamin D supplementation before 60 days  An inability or unwillingness to participate Those who are already taking any type of vitamin D supplements Individuals with a history of allergy Those subjects with serious medical condition such as cancer, heart attack, stroke, and etc Illness that required corticosteroids or insulin Drugs are known to influence vitamin D level; steroids, anti-acids, oestrogen People with conditions that contradict vitamin D supplementation, for example, a history of hypercalcaemia, hepatic disease or renal stones, sarcoidosis, or malignancy
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Insomnia Chronic a) >= 18 years, b) access to high speed internet and computer, c) disturbance of sleep consisting of a delay in sleep onset, return to sleep or early morning awakening at least 3 nights/week for at least 3 months in duration, d) at least one symptom of daytime impairment, use of medication to promote sleep, e) use of medication to promote sleep (either <= 1mg lorazepam, <= .5mg clonazepam, <= 7.5mg zopiclone, <= 50 mg trazodone/amitriptyline, f) interested in medication tapering  a) shift work, b) head injury, c) acute crisis, d) seizure disorder, e) use of psychotropic drugs for problems other than sleep, f) use of medication interfering with sleep, g) recreational drug use, h) symptoms suggestive of alternative sleep disorder that is untreated, i) elevated use of alcohol (> 14 beverages/week for males, >12 beverages per week for females)
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 19.0-45.0,  Healthy Healthy male volunteer 19 years to 45 years Body mass index in the range of 18 to 29 kg/m2 and body weight greater than 50 kg The subjects personally signed and dated informed consent document after informed of all pertinent aspects of the study, fully understanding and determided spontaneously to participate  Subject with serious active cardiovascular, respiratory, hepatologic, renal, hematologic, endocrine, urologic, immunologic, dermal, neurologic, or psychological disease or history of such disease Subject with acute disease within 28 days before the first dose of Investigational product Subject with known for history of disease which affect on the absorption, distribution, metabolism, excretion of drug Subjects who are unwilling or unable to use highly effective methods of contraception as outlined in this protocol for the duration of the study
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Sleep Apnea Syndromes Epilepsies, Partial Male or female age ≥ 18 Patient suffering of pharmacoresistant epilepsy Frequency of epilepsy crisis : minimum 4 per month Antiepileptic drug on a stable dose for at least 2 months SA-SDQ score ≥ 25 Written informed consent obtained Patient affiliated with a social security regimen  Pregnant females (female subjects who are lactating are not excluded) Anterior CPAP treatment Central apnea >20% during the initial polysomnography Mental retardation or severe cognitive impairment Presence of pseudo-crisis
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-99.0,  Esophageal Squamous Cell Carcinoma All suspected ESCC cases will be eligible for enrollment All KCH and St Gabriel s patients greater than or eqaul to 18 years of age who are residents of the Central Region of Malawi and are diagnosed with histology-confirmed ESCC will be invited to participate as cases in the study  Patients <18 years old Those living outside the Central Region, those who are medically unable to complete the study procedures (including questionnaire, biosample collection or endoscopy), and those who are unable to understand the study procedures or give informed consent. While we do expect to see younger people with ESCC in Malawi (as we have seen in Kenya), cases under the age of 18 are rare: the field team would expect to see one or two a year. This estimate is in line with the cancer registry data from Malawi. Therefore, we will not enroll subjects younger than 18 years old
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Ultrasonography, Prenatal Pregnant women above 172 cm height above 39 weeks of gestation  contraindication for vaginal delivery Intrauterus growth restriction
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Obesity BMI greater than or equal to 40 kg/m2, greater than or equal to to 30 kg/m2 with 1 more obesity related co-morbidity, or or greater than or equal to 35 kg/m2 without co-morbidity Co-morbidities 1. Sleep apnea (STOP-BANG questionnaire and polysomnography) 2. BP >130/80 or on hypertension meds. 3. A1c > or = to 5.7, fasting >100 OR >126, 6.5 and above 4. Waist circumference >102, or 40 inches if male or >80 cm 35 inches if female 5. Metabolic syndrome (3 blood pressure, waist circumference, triglycerides > 150 or HDL < 50/40) Failure to respond to non-invasive weight loss management for at least 6 months Valid health insurance to cover the cost of procedure and standard of care pre-and post-procedure management/workup  Untreated endocrine diseases (diabetes, thyroid disorder, pituitary disorder, and sex gland disorder) diabetes or A1c >6.5 Heart Disease, for example, arrhythmia, heart failure, myocardial infarction Kidney disease with serum creatinine greater than 2.5 mg/dl Cerebrovascular disease, for example, stroke or otherwise unable to exercise Any pregnant or lactating women or who have had childbirth within 6 months Any patients on retinoid therapy or undergoing retinoid therapy that will not last throughout the length of the trial Patients with significant psychiatric disorder Any other chronic condition deemed unsuitable to undergo either arm of the trial